Skip to main content

DAVITA INC

For the period ended Mar 31, 2024. Filed May 2, 2024.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Mar 31, 2024 · Filed May 2, 2024

DVA$191.35-1.8%Stored close · as of Nov 6, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Consolidated Statements of Income for the three months ended March 31, 2024 and March 31, 2023

CONSOLIDATED STATEMENTS OF INCOME

Three months ended March 31,Three months ended March 31,
20242023
Dialysis patient service revenues$2,941,532$2,760,034
Other revenues129,023112,665
Total revenues3,070,5552,872,699
Operating expenses:
Patient care costs2,078,9762,058,189
General and administrative362,480331,614
Depreciation and amortization187,083178,071
Equity investment income, net(6,682)(6,820)
Gain on changes in ownership interest(35,147)—
Total operating expenses2,586,7102,561,054
Operating income483,845311,645
Debt expense(99,418)(100,774)
Other (loss) income, net(12,641)3,752
Income before income taxes371,786214,623
Income tax expense65,80643,955
Net income305,980170,668
Less: Net income attributable to noncontrolling interests(66,331)(55,121)
Net income attributable to DaVita Inc.$239,649$115,547
Earnings per share attributable to DaVita Inc.:
Basic net income$2.73$1.28
Diluted net income$2.65$1.25
Weighted average shares for earnings per share:
Basic shares87,77590,497
Diluted shares90,54792,483
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.